Press Release: Melior Discovery : Visikol and Melior Discovery Partner on Precision Cut Liver Ex Vivo NASH Models

Visikol is a leading provider of advanced cell culture assays and has recently been expanding its portfolio of in vitro assays through the introduction of precision cut tissue slice models. By culturing fresh tissue in an ex vivo format, an unprecedented level of relevancy can be achieved in a medium throughput in vitro assay. As a service provider that is agnostic to the types of models used in its assays, Visikol is continually looking to expand its model portfolio such that every researcher can choose a model which best meets their throughput, relevancy, and cost needs, as no single model is best for all research questions. Through this partnership, Visikol will leverage Melior Discovery's CCl4-induced mouse liver fibrosis model to provide its Clients with an alternative or supplement to using human-based models in their NASH drug discovery efforts.(PRWeb September 28, 2020)Read the full story at https://www.prweb.com/releases/visikol_and_melior_discovery_partner_on_precision_cut_liver_ex_vivo_nash_models/prweb17374795.htm